Mỏ neo trong cơn bão: Stablecoin định hình lại bối cảnh tài chính toàn cầu như thế nào?

Cell Microsystems

company

About

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single-cell biology.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.90M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single-cell biology. The company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the company’s automated imaging platform, a user can select a cell in real-time and ‘track and trace’ that cell through imaging, collection, and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single-cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.90M
Cell Microsystems has raised a total of $1.90M in funding over 2 rounds. Their latest funding was raised on Apr 23, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 23, 2019 Grant $1.90M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cell Microsystems is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant